Načítá se...

Recent advances in the generation of human monoclonal antibody

The use of monoclonal antibodies (mAbs) has now gained a niche as an epochal breakthrough in medicine. Engineered antibodies (Abs) currently account for over 30% of biopharmaceuticals in clinical trials. Several methods to generate human mAbs have evolved, such as (1) immortalization of antigen-spec...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Yamashita, Makiko, Katakura, Yoshinroi, Shirahata, Sanetaka
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Netherlands 2007
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2104546/
https://ncbi.nlm.nih.gov/pubmed/19002994
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10616-007-9072-5
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!